Professor Günter Höglinger, Lead Investigator of the Mascot trial, said: “Completing randomization of a global Phase 3 trial in MSA is a significant achievement for the field.” He added: “Advancing ...
Traditional epidemiological studies have identified numerous potential risk factors, but observational studies have struggled to establish causal links due to confounding factors and reverse causation ...
Genetic data linked FGF21 signalling to lower problematic alcohol use and ARLD risk. Learn how this liver–brain pathway may reshape treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results